• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Real-World Evidence: Real World Uses and the Regulatory Vision Forward


Sponsored Video

Pharm Exec’s Lisa Henderson, Scott Gottlieb, MD, Former FDA Commissioner, and experts from Parexel talk about the COVID-19 pandemic and how its enormous impact on our medical systems has accelerated the growth in and adoption of RWE.

A New Era of Real-World Evidence

Breaking New Ground with RWE

Learn More:

Real-World Evidence: State-of-the-Art, Current Challenges and Future Vision
Recent roundtable brought together by Pharm Exec and Parexel features insights from leaders in the pharma industry on the current state and future of RWE.

Related Videos
Jason Tate, FSP Talent Strategy Lead, PPD, part of Thermo Fisher Scientific
Corevitas Clinical Trials